Bill Search

  • Introduced
    Feb 21, 2023
  • Passed House
    Apr 28, 2023
  • Passed Senate
    May 15, 2023
  • Signed into Law
    Jun 17, 2023
HB 2545
Texas House Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
Relating to an individual's genetic data, including the use of that data by certain genetic testing companies for commercial purposes and the individual's property right in DNA; authorizing a civil penalty.
Last Action See all actions
executive • Jun 17, 2023: Effective on 9/1/23
Latest Bill Text See all bill texts

Summary/Bill Text

Comments on HB 2545

Tweets

Whip Lists

Sponsors
Votes
Actions
  • Jun 17, 2023 | executive
    • Signed by the Governor
    • Effective on 9/1/23
  • May 22, 2023 | executive
    • Sent to the Governor
  • May 21, 2023 | Senate
    • Signed in the Senate
  • May 19, 2023 | House
    • Signed in the House
  • May 18, 2023 | House
    • Reported enrolled
  • May 17, 2023 | Senate
    • House concurs in Senate amendment(s)-reported
  • May 17, 2023 | House
    • House concurs in Senate amendment(s)
    • Record vote RV#1807
    • Text of Senate Amendment(s)
  • May 16, 2023 | House
    • Senate Amendments distributed
    • Senate Amendments Analysis distributed
  • May 15, 2023 | House
    • Senate passage as amended reported
  • May 15, 2023 | Senate
    • Co-sponsor authorized
    • Rules suspended-Regular order of business
    • Read 2nd time
    • Amendment(s) offered FA1 Johnson
    • Amended
    • Vote recorded in Journal
    • Passed to 3rd reading as amended
    • Vote recorded in Journal
    • Three day rule suspended
    • Record vote
    • Read 3rd time
    • Passed
    • Record vote
  • May 12, 2023 | Senate
    • Placed on intent calendar
  • May 10, 2023 | Senate
    • Reported favorably as substituted
    • Committee report printed and distributed
  • May 09, 2023 | Senate
    • Considered in public hearing
    • Vote taken in committee
  • May 04, 2023 | Senate
    • Co-sponsor authorized
    • Scheduled for public hearing on . . . 05/04/2023
    • Considered in public hearing
    • Testimony taken in committee
    • Left pending in committee
  • May 01, 2023 | Senate
    • Received from the House
    • Read first time
    • Referred to Business & Commerce
  • Apr 28, 2023 | House
    • Placed on Local, Consent, and Res. Calendar
    • Read 2nd time
    • Passed to engrossment
    • Read 3rd time
    • Passed
    • Record vote RV#681
    • Statement(s) of vote recorded in Journal
    • Reported engrossed
  • Apr 25, 2023 | House
    • Considered in Local & Consent Calendars
  • Apr 18, 2023 | House
    • Comte report filed with Committee Coordinator
    • Committee report distributed
    • Comm. report sent to Local & Consent Calendar
  • Apr 05, 2023 | House
    • Considered in formal meeting
    • Committee substitute considered in committee
    • Recommended to be sent to Local & Consent
    • Reported favorably as substituted
  • Mar 27, 2023 | House
    • Scheduled for public hearing on . . . 03/27/2023
    • Considered in public hearing
    • Committee substitute considered in committee
    • Testimony taken/registration(s) recorded in committee
    • Left pending in committee
  • Mar 13, 2023 | House
    • Read first time
    • Referred to Business & Industry
  • Feb 21, 2023 | House
    • Filed